Abstract
GSTM1, GSTT1 and GSTP1 Ile105Val that are members of the GST gene family encode for Phase II drug/xenobiotic metabolizing enzymes, primarily with detoxifying function, and are polymorphic in humans. GSTM1 and GSTT1 homozygous deletion genotypes do not express the enzymes. It has been hypothesised that individuals with homozygous deletion of the GSTM1 and/or GSTT1 gene may have lower detoxification capacity towards genotoxic agents therefore those individuals may be at increased risk of myelodysplastic syndrome which is a preleukemic condition. Genetic polymorphism of GSTM1, GSTT1 and GSTP1 Ile105Val was investigated in a case–control study in a Hungarian patient population comprising 86 patients with myelodysplastic syndrome and 99 hospital-based controls. There were no statistically significant differences between cases and controls for the GSTM1, GSTT1 and GSTP1 Ile105Val genotype frequencies for any of the three genes separately and in various combinations. This suggests that these genetic polymorphisms may not be strong risk factors, if any, for myelodysplastic syndrome.
Similar content being viewed by others
References
Farrow A, Jacobs A, West RR (1989) Myelodysplasia, chemical exposure and other environmental factors. Leukemia 3:33–35
Kim SY, Choi JK, Cho YH, Chung EJ, Paek D, Chung HW (2004) Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 14:453–463
Mannervik B, Danielson H (1988) Glutathione transferases—structure and catalytic activity. CRC Crit Rev Biochem 23:283–337
Vineis P, Malats N, Lang M, d’Errico A, Caporaso N, Cuzick J, Boffetta P (eds) (1999) Metabolic polymorphisms and susceptibility to cancer. International Agency for Research on Cancer, Lyon, pp 51–62
Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF (1998) Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1 and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomark Prev 7:1013–1018
Geisler S, Olshan A (2001) GSTM1, GSTT1 and risk of head and neck cancer: a mini-HuGE review. Am J Epidemiol 154:95–105
Watson MA, Stewart PK, Smith GB, Massey TE, Bell DA (1998) Human glutathione S-transferase P1 polymorphisms, relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275–280
Srivastava SK, Singhal SS, Hu X, Awasthi YC, Zimniak P, Singh SV (1999) Differential catalytic efficiency of allelic variants of human glutathione S-transferase α in catalyzing the glutathione conjugation of thiothepa. Arch Biochem Biophys 366:89–94
Lecomte T, Landi B, Beaune Ph, Puig PL, Lirot MA (2006) Glutathione S-transferase P1 polymorphism (Ile 105 Val) predicts cumulative neuropathy in patients receiving oxiplatin-based chemotherapy. Clin Cancer Res 12:3050–3056
Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295–297
Ozawa S, Schoket B, McDaniel LP, Tang Y-M, Ambrosone CB, Kostic Sz, Vincze I, Adlubar FF (1999) Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases. Carcinogenesis 20:991–995
Landi S (2000) Mammalian class theta GST and different susceptibility to carcinogens: a review. Mutat Res 463:247–283
Cotton SC, Sharp L, Little J, Brockton N (2000) Gluthation S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151:7–32
Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell’Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomark Prev 10:1239–1248
Atoyebi W, Kusec R, Fidler C, Peto TEA, Boultwood J, Wainscoat JS (1997) Glutathione S-transferase gene deletions in myelodysplasia. Lancet 349:1450–1451
Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H, Kashima K, Taniwaki M (1999) Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 23:975–981
Ozbek U, Aydin-Sayitoglu M, Hatirnaz O, Erensoy N (2005) Role of CYP1A1, CYP2E1, GSTT1 and GSTM1 genes in the susceptibility to acute leukemias. Haematologica S2: Abstr 0585
Tsabouri S, Georgiou I, Alamanso I, Bourantas KL (2000) Increased prevalence of GSTM1 null genotype in MDS patients. Acta Haematol 104:169–173
Arruda VR, Lima CS, Grignoli CR, deMelo MB, Lorand-Metze I, Alberto FL, Saad ST, Costa FF (2001) Increased risk for acute myeloid leukaemia in individuals with glutathion S-transferase mu-1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol 66:383–388
Davies SM, Robinson LL, Buckley JD, Radolff GA, Ross JA, Perentesis JP (2000) Gluthation S-transferase polymorphisms in children with myeloid leukemia: a Children’s Cancer Group study. Cancer Epidemiol Biomark Prev 9:563–566
Haase D, Schulz TG, Heutelbeck A, Fonatsch C, Harder L, Griesinger F, Hallier E, Trümper L (2003) Polymorphisms of metabolizing enzymes (NAT2, GSTT1, GSTM1 and GSTP1) in de novo and therapy-induced MDS and AML. 7th International Symposium on Myelodysplastic Syndromes. Leuk Res 27(1):S1–S2
Acknowledgements
This study was supported by the “Judy Rák Alapítvány” foundation and ETT 279/2003. The technical assistance by Ms. Lívia Anna and Gizella Papp are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Várkonyi, J., Szakály, D., Jánoskúti, L. et al. Glutathione S-Transferase Enzyme Polymorphisms in a Hungarian Myelodysplasia Study Population. Pathol. Oncol. Res. 14, 429–433 (2008). https://doi.org/10.1007/s12253-008-9008-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-008-9008-1